Patience John's Insider Trades & SAST Disclosures
Patience John's most recent trade in Accelerate Diagnostics Inc was a trade of 200,000 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Dec. 3, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patience John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc | Patience John | Director | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 03 Dec 2024 | 200,000 | 653,224 (1%) | 0% | 1.6 | 314,000 | Common Stock |
| Biodesix Inc | John Patience | Director, Chairman | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 05 Nov 2024 | 75,000 | 2,153,298 | - | 1.4 | 103,710 | Common Stock |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 217,400 | 4,829,611 | - | - | Common Stock | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 5,435 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Accelerate Diagnostics Inc | John Patience | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 66,667 | 66,667 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 5,435 | 5,435 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Accelerate Diagnostics Inc | John Patience | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 16,666 | - | - | Common Stock Warrants (right to buy) | |
| Accelerate Diagnostics Inc | Patience John | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 453,224 (0%) | 0% | - | Common Stock | |
| Biodesix Inc | Patience John | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 105,389 | 134,262 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 61,728 | 4,612,211 | - | 1.6 | 99,999 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 236,842 | 236,842 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | John Patience | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2023 | 78,947 | 78,947 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 28,873 | 28,873 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 4,878 | 150,711 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 62,500 | 145,833 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 21 Nov 2022 | 1,739,130 | 4,550,483 | - | 1.2 | 2,000,000 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 75,949 | 75,949 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 83,333 | 83,333 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 07 Apr 2022 | 279,329 | 337,926 | - | 1.8 | 499,999 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 30 Dec 2021 | 137,931 | 2,078,298 | - | 4.4 | 600,000 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 30 Dec 2021 | 22,988 | 52,988 | - | 4.4 | 99,998 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 6.18 per share. | 23 Nov 2021 | 10,000 | 1,940,367 | - | 6.2 | 61,753 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 6.34 per share. | 18 Nov 2021 | 9,497 | 1,930,367 | - | 6.3 | 60,220 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 30 Sep 2021 | 21,702 | 4,365,585 (7%) | 0% | 7.7 | 166,671 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 8.04 per share. | 19 Aug 2021 | 8,396 | 1,920,870 | - | 8.0 | 67,490 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 7.12 per share. | 17 Aug 2021 | 1,604 | 1,912,474 | - | 7.1 | 11,416 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 34,385 | 34,385 | - | - | Stock Options (Right to buy) | |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 35,168 | 35,168 | - | - | Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 09 Apr 2021 | 21,701 | 4,343,883 (7%) | 0% | 7.7 | 166,664 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 19 Feb 2021 | 21,701 | 4,322,182 (7%) | 0% | 7.7 | 166,664 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 35,157 | 1 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.83 per share. | 07 Dec 2020 | 35,157 | 35,157 | - | 6.8 | 240,122 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 23,440 | 11,718 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.83 per share. | 07 Dec 2020 | 23,440 | 58,597 | - | 6.8 | 160,095 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 6,711,816 | 0 | - | - | Series G Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 4,182,413 | 0 | - | - | Series H Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 3,205,681 | 0 | - | - | Series F Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 3,055,837 | 0 | - | - | Series F Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 2,932,534 | 0 | - | - | Series D Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 2,501,974 | 2,501,974 | - | - | Common Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 1,829,368 | 1,829,368 | - | - | Common Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 1,484,624 | 0 | - | - | Series E Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 1,454,545 | 0 | - | - | Series B Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 1,250,000 | 0 | - | - | Series B-1 Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 957,114 | 0 | - | - | Series G Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 809,200 | 0 | - | - | Series E Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 666,666 | 0 | - | - | Series C Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 250,000 | 0 | - | - | Series D Preferred Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 245,041 | 2,747,015 | - | - | Common Stock | ||
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 81,600 | 1,910,968 | - | 14.4 | 1,175,040 | Common Stock | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | 23 Jun 2020 | 64,416 | 2,811,431 | - | 14.4 | 927,590 | Common Stock | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 23 Jun 2020 | 30,000 | 30,000 | - | 18 | 540,000 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 13,779 | 13,779 | - | - | Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.83 per share. | 24 Mar 2020 | 5,000 | 4,196,211 (7%) | 0% | 6.8 | 34,150 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.83 per share. | 24 Mar 2020 | 5,000 | 4,300,481 (7%) | 0% | 6.8 | 34,150 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges